Foundation Fighting Blindness: Kiora Receives Authorization for Phase 2 Clinical Trial of Its Photoswitch for Advanced RP
October 30, 2024
October 30, 2024
COLUMBIA, Maryland, Oct. 30 -- The Foundation Fighting Blindness issued the following news:
* * *
The 36-participant trial will take place at multiple sites in Australia.
* * *
Kiora Pharmaceuticals, a company developing treatments for orphan retinal diseases, has received authorization in Australia to launch the Phase 2 ABACUS-2 clinical trial for its photoswitch, a small molecule that is designed to restore some vision to people with advanced . . .
* * *
The 36-participant trial will take place at multiple sites in Australia.
* * *
Kiora Pharmaceuticals, a company developing treatments for orphan retinal diseases, has received authorization in Australia to launch the Phase 2 ABACUS-2 clinical trial for its photoswitch, a small molecule that is designed to restore some vision to people with advanced . . .